← Every applicant
Deva Holding As FDA Approvals
10 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| MIRABEGRONNew drugMay 1, 2026TABLET, EXTENDED RELEASE, ORAL |
| ISOPROTERENOL HYDROCHLORIDENew drugDec 10, 2025INJECTABLE, INJECTION |
| LEVOCARNITINENew drugJun 30, 2025INJECTABLE, INJECTION |
| LENALIDOMIDENew drugMay 22, 2025CAPSULE, ORAL |
| PANTOPRAZOLE SODIUMNew drugMay 16, 2025INJECTABLE, INTRAVENOUS |
| FORMOTEROL FUMARATENew drugFeb 11, 2025SOLUTION, INHALATION |
| CYCLOSPORINENew drugMay 21, 2024EMULSION, OPHTHALMIC |
| AMOXICILLIN AND CLAVULANATE POTASSIUMNew drugDec 11, 2023FOR SUSPENSION, ORAL |
| AMOXICILLIN AND CLAVULANATE POTASSIUMNew drugNov 29, 2023FOR SUSPENSION, ORAL |
| AMOXICILLIN AND CLAVULANATE POTASSIUMNew drugSep 13, 2023FOR SUSPENSION, ORAL |